Business Context and Reporting Period
Company: DNA X, Inc. (Ticker: SONM)
Filing Type: Form 8-K (Current Report)
Date of Report: April 14, 2026
Reporting Period: Fiscal Quarter Ended December 31, 2025
This filing serves as a notification that the Company issued a press release on April 14, 2026, announcing its financial results for the quarter ended December 31, 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text acts as a cover document and does not contain specific financial data points. The following metrics are not disclosed in this text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the attached Press Release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary and Guidance: The filing text does not include specific guidance, outlook, or management commentary. These details are contained within the referenced Press Release (Exhibit 99.1).
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended December 31, 2025.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any forward-looking statements or updated guidance provided in the press release.
- Confirm the trading status of Common Stock (SONM) on the Nasdaq Capital Market.